BPC-157 Protects Against Diclofenac-Induced Multi-Organ Damage: Gut, Liver, and Brain
BPC-157 attenuated diclofenac-induced gastrointestinal, liver, and encephalopathy damage in rats — comprehensive multi-organ NSAID toxicity protection from a single peptide agent.
Quick Facts
What This Study Found
BPC-157 attenuated diclofenac-induced gastrointestinal, liver, and encephalopathy damage in rats — comprehensive multi-organ NSAID toxicity protection from a single peptide agent.
Key Numbers
How They Did This
research study.
Why This Research Matters
Relevant for peptide research.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
Trust & Context
- Key Stat:
- Key finding BPC-157 attenuated diclofenac-induced gastrointestinal, liver, and encephalopathy damage in rats — comprehensive multi-organ NSAID toxicity protection
- Evidence Grade:
- emerging evidence.
- Study Age:
- Published in 2011.
- Original Title:
- Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions.
- Published In:
- Life sciences, 88(11-12), 535-42 (2011)
- Authors:
- Ilic, Spomenko(7), Drmic, Domagoj(20), Franjic, Sandra, Kolenc, Danijela, Coric, Marijana, Brcic, Luka, Klicek, Robert, Radic, Bozo, Sever, Marko, Djuzel, Viktor, Filipovic, Marinko, Djakovic, Zeljko, Stambolija, Vasilije, Blagaic, Alenka Boban, Zoricic, Ivan, Gjurasin, Miroslav, Stupnisek, Mirjana, Romic, Zeljko, Zarkovic, Kamelija, Dzidic, Senka, Seiwerth, Sven, Sikiric, Predrag
- Database ID:
- RPEP-01783
Evidence Hierarchy
Frequently Asked Questions
What was studied?
BPC-157 Protects Against Diclofenac-Induced Multi-Organ Damage: Gut, Liver, and Brain
What was found?
BPC-157 attenuated diclofenac-induced gastrointestinal, liver, and encephalopathy damage in rats — comprehensive multi-organ NSAID toxicity protection from a single peptide agent.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01783APA
Ilic, Spomenko; Drmic, Domagoj; Franjic, Sandra; Kolenc, Danijela; Coric, Marijana; Brcic, Luka; Klicek, Robert; Radic, Bozo; Sever, Marko; Djuzel, Viktor; Filipovic, Marinko; Djakovic, Zeljko; Stambolija, Vasilije; Blagaic, Alenka Boban; Zoricic, Ivan; Gjurasin, Miroslav; Stupnisek, Mirjana; Romic, Zeljko; Zarkovic, Kamelija; Dzidic, Senka; Seiwerth, Sven; Sikiric, Predrag. (2011). Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions.. Life sciences, 88(11-12), 535-42. https://doi.org/10.1016/j.lfs.2011.01.015
MLA
Ilic, Spomenko, et al. "Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions.." Life sciences, 2011. https://doi.org/10.1016/j.lfs.2011.01.015
RethinkPeptides
RethinkPeptides Research Database. "Pentadecapeptide BPC 157 and its effects on a NSAID toxicity..." RPEP-01783. Retrieved from https://rethinkpeptides.com/research/ilic-2011-pentadecapeptide-bpc-157-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.